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TO THE EDITOR
Cancers of the skin are the most
common cancers to afflict Americans
in the United States with over
1,000,000 new cases estimated to
occur in 2008 (ACS, 2008). The primary
environmental factor that influences the
development of skin cancer is exposure
to sunlight, in the ultraviolet B (UVB)
wavelengths. Notably, a dramatic in-
crease in the incidence of skin cancers
is seen with increasing age (ACS, 2008),
as evidenced by the fact that a majority
of skin malignancies are found in
people over the age of 60 years
(Kraemer, 1997; ACS, 2008). However,
the mechanisms underpinning the cor-
relation between age and skin cancer
are not well understood. New ideas on
the link between age and skin cancer
have arisen based on age-related accu-
mulation of stromal senescent cells that
can lead to a tumor-promoting environ-
ment (Krtolica et al., 2001; Krtolica and
Campisi, 2002; Dilley et al., 2003;
Parrinello et al., 2005; Collado et al.,
2007). Combining these recent data
from others with data from our labora-
tory leads us to propose a new para-
digm for the role of aging in the
development of skin cancer involving
the insulin-like growth factor-1 receptor
(IGF-1R) pathway (Kuhn et al., 1999;
Chuang et al., 2005; Heemst et al.,
2005; Kurosu et al., 2005; Samani
et al., 2005; Lewis and Spandau,
2008; Lewis et al., 2008).
The historical explanation for the
correlation between skin cancer and
aging is that UVB-induced skin damage
during childhood and early adoles-
cence initiates mutations in keratino-
cytes (Kraemer, 1997; Whiteman et al.,
2001; Krtolica and Campisi, 2002;
MacKie, 2006; Feng et al., 2007).
Subsequently, these keratinocytes con-
taining mutations acquire a growth
advantage that over many decades
generates enough genetic change to
become carcinogenic. However, can
we presume that time is the sole
contributor to UVB-induced skin can-
cers? It is reasonable to consider that
the physiology of aging also lends a
hand to carcinogenic events. Recent
data from a variety of labs have
demonstrated a modification on the
theory of skin cancer and aging based
on changes in stromal fibroblasts of
aged individuals. There are age-related
increases in the number of senescent
dermal fibroblasts and epidermal kera-
tinocytes in human skin (Dimiri et al.,
1995). In a study involving aging
primates, an age-dependent increase
in markers of senescence in skin fibro-
blasts was observed (Herbig et al.,
2006; Jeyapalan et al., 2007). Given
this age-associated accumulation of
senescent cells, it is reasonable to
propose that cellular senescence may
contribute to age-related cancers by
altering the surrounding tissue into a
neoplasia-promoting environment. The
paradoxical effect of cellular senes-
cence on an organism’s well-being has
been called antagonistic pleiotropy
(Williams, 1957; Krtolica and Campisi,
2002). However, cellular senescence is
a powerful tumor suppressor limiting
cell life span and removing damaged
cells from a proliferative state prevent-
ing formation of clonal tumors (Campisi,
2005; Hornsby, 2007; Rodier et al.,
2007). Conversely, the accumulation of
senescent cells may contribute to aging
and provide a tumor-promoting envir-
onment due to their altered properties
such as stromal matrix reorganization
and/or degradation, secretion of growth
factors, and inflammatory cytokines
(Krtolica and Campisi, 2002; Parinello
et al., 2005). Here we present our data
proposing a new paradigm to explain
non-melanoma skin carcinogenesis that
further substantiates the importance of
stromal interactions in the progression
of carcinogenic events. The stromal
interactions discussed demonstrate that
IGF-1 and the IGF-1R are critical in the
interactions between dermal fibroblast
and epidermal keratinocytes and that
they play an important role in aging and
the response of skin to UVB irradiation.Abbreviations: NMSC, non-melanoma skin cancer; UVB, ultraviolet B
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The stroma and some basement
membrane components are synthesized
by stromal fibroblasts that also produce
soluble factors that promote survival
and growth of the skin. The health and
proper functioning of the skin is highly
dependent on the synergistic interac-
tions between the dermal fibroblasts
and epidermal keratinocyte. One factor
regulating the interaction between der-
mal fibroblasts and epidermal keratino-
cytes is IGF-1 (Barreca et al., 1992;
Tavakkol et al., 1992). In the skin,
keratinocytes express the IGF-1R but
do not synthesize IGF-1. Dermal fibro-
blasts support the appropriate develop-
ment of epidermal keratinocytes by
secreting IGF-1. The mature IGF-1R
consists of four subunits, two identical
extracellular a- and two identical trans-
membrane b-subunits linked by disul-
fide bridges. IGF-1, IGF-2, and high
concentrations of insulin can activate
the IGF-1R resulting in tyrosine kinase
activity. Subsequently, binding or phos-
phorylation of cellular substrates in
close proximity through SH2 binding
domain leads to downstream signaling
(Figure S1). The importance of IGF-1R
signaling in skin development is clearly
evident from a variety of studies.
Transgenic mice overexpressing IGF-1
in the basal layer of skin epidermis
exhibited epidermal hyperplasia, hy-
perkeratosis, and squamous papillomas
(Bol et al., 1997; Wilker et al., 1999;
DiGiovanni et al., 2000). Conversely,
IGF-1R knockout mice demonstrate
severe hypoplasia (Lui et al., 1993).
The IGF-1R has also been shown to be
important in normal epidermal differ-
entiation (Sadagurski et al., 2006)
whereas other reports have identified a
key role for the IGF-1R in regulating the
response of cells to oxidative stress
(Holzenberger et al., 2003; Ikushima
et al., 2006). Therefore, the activation
of the IGF-1R can influence all stages of
epidermal homeostasis.
Experiments that assessed the role of
various growth factors on the response
of keratinocytes to UVB irradiation
identified that the activation status of
the IGF-1R was a critical component
affecting UVB-induced apoptosis
in vitro (Figure 1; Kuhn et al., 1999).
Inhibition of the IGF-1R, by ligand
withdrawal, treatment with neutralizing
antibodies, or treatment with IGF-1R-
specific small molecule inhibitors be-
fore irradiation increased the sensitivity
of keratinocytes to UVB-induced apop-
tosis (Kuhn et al., 1999; Lewis et al.,
2006, 2008; Lewis and Spandau, 2007,
2008). For simplicity in this review,
keratinocytes grown in conditions that
permit the functional activation of the
IGF-1R will be called (þ )IGF-1R kera-
tinocytes whereas cells containing
functionally inactive IGF-1Rs will be
referred to as ()IGF-1R keratinocytes
(Lewis and Spandau, 2008, Lewis et al.,
2008). It is important to note that the
expression of the IGF-1R protein is
equal in both (þ )IGF-1R and ()IGF-
1R keratinocytes; they only differ in the
activation status of the IGF-1R. These
studies identified that the functional
activation of the IGF-1R provided pro-
tection to human keratinocytes from
UVB-induced apoptosis. However, an
(+)IGF-1R and (–)IGF-1R
keratinocytes
(+)IGF-1R and (–)IGF-1R
keratinocytes
(+)IGF-1R
keratinocytes
(–)IGF-1R
keratinocytes
Low doses of UVB
mild DNA damage
High doses of UVB
extensive DNA damage
Intermediate doses of UVB
substantial DNA damage
Complete repair of DNA damage
keratinocytes proliferate
and
Incomplete DNA repair
increased susceptibility
to apoptosis
Incomplete DNA repair
cell proliferation with
UVB-damaged DNA
No DNA repair
keratinocytes undergo apoptosis
Incomplete DNA repair
keratinocytes survive but
become senescent
Figure 1. Keratinocyte UVB response in vitro. At low and high doses of UVB, the activation status of the IGF-1R does not influence the response of
keratinocyte to UVB irradiation. However, at intermediate doses of UVB, the response of the keratinocytes following UVB exposure is dependent on the status
of the IGF-1R. If the IGF-1R is functionally active, keratinocytes undergo stress-induced premature senescence and the unrepaired DNA damage cannot be
passed to progeny. If the IGF-1R is functionally inactive during UVB irradiation, keratinocytes are more likely to undergo apoptosis; however, surviving
keratinocytes continue to proliferate in the presence of UVB-damaged DNA.
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equally important observation was that
these surviving keratinocytes cannot
replicate and become senescent (Fig-
ure 1; Kuhn et al., 1999; Lewis et al.,
2008). We propose this UVB response
occurs in the epidermis where the
induction of senescence in response to
UVB irradiation is a tumor evasion
mechanism that maintains the impor-
tant barrier function of the epidermis
while ensuring keratinocytes cannot
proliferate in the presence of irrepar-
able UVB-induced DNA damaged. If
the IGF-1R is functionally inactive at
the time of UVB irradiation, a portion of
the keratinocytes will undergo apopto-
sis; however, keratinocytes that survive
do not become senescent, do not repair
UVB-damaged DNA, and they can
continue to proliferate with the poten-
tial of converting the damaged DNA
into initiating carcinogenic mutations
(Lewis et al., 2008).
Data generated from our lab (Cotton
and Spandau, 1997; Lewis et al., 2008)
and many others (Qin et al., 2002;
Chaturvedi et al., 2004; Chaturvedi
et al., 2005) have demonstrated that
UVB irradiation of keratinocytes initi-
ates a DNA damage response involving
the phosphorylation of the tumor sup-
pressor p53. Recently, we have shown
that UVB activation of p53 is also
dependent on the status of the IGF-1R
(Lewis et al., 2008). Activation of the
IGF-1R resulted in higher levels of
UVB-induced total p53 protein and
increased phosphorylation at serine 15
(p53S15) and serine 46 (p53S46) (Lewis
et al., 2008). Intriguingly, the phosphory-
lation of p53S46 was only observed in
(þ )IGF-1R keratinocytes and was not
influenced by UVB irradiation (Lewis
et al., 2008). The UVB response of
keratinocytes expressing a p53 gene
where serine 46 is replaced by glutamic
acid (p53S46D; which structurally and
functionally mimics a phosphorylated
serine residue) was found to be inde-
pendent of the activation status of the
IGF-1R. These data indicate that the
UVB response of keratinocytes (senes-
cence and apoptosis) requires a func-
tional IGF-1R and the subsequent
downstream phosphorylation of p53S46.
Our in vitro data showing IGF-1R
activation status was an important
factor in the response of epidermal
keratinocytes to UVB led us to hypo-
thesize that the reduced activation of
the IGF-1R may be correlated with an
increased susceptibility to skin cancer
in vivo. In a retrospective epidemiolo-
gical study, we found that type 2
diabetic patients using insulin to treat
their disease had a 2.5-fold decreased
risk of developing NMSC over the
control group and type 2 diabetic
patients using non-insulin medicines
to treat their disease (Chuang et al.,
2005). Intriguingly, the protective effect
of insulin use increased with age,
implying that insulin was somehow
protecting against the age-associated
increase in NMSC (Chuang et al.,
2005). These important data suggested
the clinical relevance for the involve-
ment of the IGF-1R signaling pathway
in NMSC in vivo. Recently, we have
started to examine the age-related
changes in the IGF-1/IGF-1R signal
transduction pathway in vivo. Our lab
and others have shown that production
of IGF-1 diminishes as fibroblasts be-
come senescent (Ferber et al., 1993;
unpublished data). Given the critical
role of dermal fibroblasts in supplying
IGF-1 to epidermal keratinocytes, an
age-related decrease in fibroblast IGF-1
may result in keratinocytes in aged
epidermis having functionally deficient
activation of IGF-1R and subsequently
Young adult skin
replicative fibroblasts
Geriatric skin
senescent fibroblasts
Appropriate UVB response
Fibroblasts: abundant IGF-1
Keratinocytes: UVB-induced
senescence
Inappropriate UVB response
Fibroblasts: little IGF-1
Keratinocytes: UVB-damage
and proliferation
Figure 2. UVB response of the skin in vivo. The integration of data from our lab on the role of the IGF-1R
and normal UVB response of keratinocytes (Figure 1) with our data describing the declining production of
IGF-1 by senescent fibroblasts has led to the following hypothesis correlating aging skin with the
development of skin cancer. Because the production of IGF-1 is silenced in aged skin, aged skin
keratinocytes are provided with a reduced supply of IGF-1. Keratinocytes in aged epidermis exposed to
UVB wavelengths in sunlight respond inappropriately to the UVB exposure. Instead of undergoing
premature stress-induced senescence, the aged keratinocytes may continue to proliferate in the presence
of UVB-damaged DNA. We believe this decrease in IGF-1 expression with advancing age is a contributor
to the increase in nonmelanoma skin cancer seen in geriatric patients.
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respond inappropriately to UVB irradia-
tion. We examined the expression of
IGF-1 in skin samples obtained from
sun-protected anatomical locations re-
presenting young adults (20–28 years
old) or geriatric individuals (465 years
old). Immunohistochemical and quan-
titative RT-PCR analysis of IGF-1 in
samples of geriatric individuals showed
a significant reduction in IGF-1 levels
when compared to young adults (un-
published data). Accordingly, keratino-
cyte activated IGF-1R levels were high
in young adult compared to virtual
absence in geriatric individuals (unpub-
lished data). It has been reported that
the difference between UVB-induced
DNA damage repair in young and aged
human skin is the rate at which DNA
damaged is cleared (Yamada et al.,
2006). However, we propose that any
DNA damage existing while cell pro-
liferation continues (such as we have
found in aged skin) leaves the possibi-
lity for the propagation of mutations.
We believe that the age-related de-
crease in IGF-1 expression, IGF-1R
inactivation, and proliferation with
DNA damage are major components
in the development of NMSC seen in
geriatric patients (Figure 2).
We believe that cellular senescence
affects the UVB response of keratino-
cytes in the epidermis through two
distinct and opposite mechanisms; one
mechanism suppresses UVB-induced
transformation of keratinocytes and the
other mechanism promotes keratino-
cyte carcinogenesis. On the positive
side, we hypothesize that keratinocytes
use stress-induced senescence as a
tumor evasion mechanism. The advan-
tage to cellular senescence versus UVB-
induced apoptosis is that senescence
maintains the cellularity of the epider-
mis, thus preserving the barrier func-
tion. In other words, widespread UVB-
induced keratinocyte apoptosis in the
epidermis will severely compromise the
epidermal barrier function whereas
UVB-induced keratinocyte senescence
will not. In this manner, the induction
of senescence in UVB-irradiated keratino-
cytes suppresses carcinogenesis. On
the negative side, cellular senescence
in dermal fibroblasts may promote
UVB-induced carcinogenesis in aging
skin. We hypothesize that IGF-1 ex-
pression by dermal fibroblasts is critical
for the appropriate response of keratino-
cytes to UVB irradiation. The silencing of
IGF-1 expression by senescent fibroblasts
might contribute to an increased initia-
tion of transformed keratinocytes by
UVB exposure. Furthermore, the altered
inflammatory phenotype of senescent
fibroblasts may promote the expansion
of clones of initiated keratinocytes.
Given the increase in NMSC inci-
dence with its associated morbidity and
cost, the prevention of these tumors has
significant importance. Present strate-
gies for tumor prevention include
avoiding excess UV exposure. For
patients with established actinic kera-
toses precursor lesions, strategies in-
clude destruction by physical
modalities as well as by topical chemo-
therapy with 5-fluorouracil or immune-
mediated destruction with topical
imiquimod (Gold and Nestor, 2006).
Though somewhat effective in treating
established pre- or low-grade cancer-
ous lesions, these treatment strategies
do not appear to effect the underlying
process by which aged skin is more
susceptible to neoplasia. If the major
deciding feature of keratinocyte re-
sponse to UVB resides in the
senescence status of the dermal fibro-
blast, then this suggests new treatments.
One possible new treatment strategy
would be to develop methods to
rejuvenate the fibroblasts to allow
production of factors such as IGF-1.
Though marketed for cosmetic pur-
poses, skin-damaging agents ranging
from chemical peels, laser resurfacing,
heating of the skin, and other ‘‘wound-
ing’’ procedures could restimulate the
expression of IGF-1 in the treated
fibroblasts (Meshkinpour et al., 2005;
DeHoratius and Dover, 2007). Since
there appears to be a protective effect of
exogenous insulin in skin cancer devel-
opment (Chuang et al., 2005), systemic
treatment with IGF-1 (currently used for
short-stature syndromes) could also be
studied (Collett-Solberg and Misra,
2008). Thus, this new paradigm of the
role of aging in the development of skin
cancer could have significant clinical
implications.
In summary, we propose that the
reduced expression of IGF-1 that char-
acterizes geriatric skin could be an
important component in the develop-
ment of aging-related non-melanoma
skin cancer. Furthermore, dermal fibro-
blasts are critical in maintaining appro-
priate activation of the keratinocyte
IGF-1R that can be ameliorated in
aged dermis by the presence of senes-
cent fibroblasts. Finally, this paradigm
suggests a role for the IGF-1R in
suppressing UVB-induced carcinogen-
esis by induction of stress-induced
keratinocyte senescence. Further study
of this model not only could allow a
better understanding of carcinogenesis,
it could provide the impetus for new
prevention strategies.
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